In vivo study and models for COVID-19 drug development


Service description

  • In vivo tests and studies that can be used for the development of a therapeutic molecule for the treatment of COVID-19.
  • SARS-CoV-2 specific models have been developed and are made available for the development of antiviral drugs. 
  • In vivo models:
    • Efficacity of compounds in a SARS-CoV-2 model (study of survival and quantification of viral load)
      • K18-hACE2 mouse model 
      • Non human primate: cynomolgus macaque
      • Golden Syrian hamster
      • Pulmonary fibrosis model (COVID-19 patients may progress to Acute Respiratory Distress Syndrome, of which a subset of survivors will develop lung fibrosis).
  • This service is designed for Biotech companies developing SARS-CoV-2 new drugs.


Materials to provide

  • Details about the request.
  • Compounds or library to test.

  • Further details on the project may be requested.
  • You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Antiviral activity testing of any type of drug (biological or small molecule).
  • Study following the specifications validated with the Expert.

Get started with your COVID-19 in vivo assays request

Please answer the fields below to be contacted by our team of scientists

COVID Labtoo 60
COVID-19 Services
Samples blood 60 2
Biological Samples
R&D mecanism 60
Experimental Services
favicon large un peu plus-1